97
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Altered fecal microbiota composition in patients with major depressive disorder.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Studies using animal models have shown that depression affects the stability of the microbiota, but the actual structure and composition in patients with major depressive disorder (MDD) are not well understood. Here, we analyzed fecal samples from 46 patients with depression (29 active-MDD and 17 responded-MDD) and 30 healthy controls (HCs). High-throughput pyrosequencing showed that, according to the Shannon index, increased fecal bacterial α-diversity was found in the active-MDD (A-MDD) vs. the HC group but not in the responded-MDD (R-MDD) vs. the HC group. Bacteroidetes, Proteobacteria, and Actinobacteria strongly increased in level, whereas that of Firmicutes was significantly reduced in the A-MDD and R-MDD groups compared with the HC group. Despite profound interindividual variability, levels of several predominant genera were significantly different between the MDD and HC groups. Most notably, the MDD groups had increased levels of Enterobacteriaceae and Alistipes but reduced levels of Faecalibacterium. A negative correlation was observed between Faecalibacterium and the severity of depressive symptoms. These findings enable a better understanding of changes in the fecal microbiota composition in such patients, showing either a predominance of some potentially harmful bacterial groups or a reduction in beneficial bacterial genera. Further studies are warranted to elucidate the temporal and causal relationships between gut microbiota and depression and to evaluate the suitability of the microbiome as a biomarker.

          Related collections

          Author and article information

          Journal
          Brain Behav. Immun.
          Brain, behavior, and immunity
          1090-2139
          0889-1591
          Aug 2015
          : 48
          Affiliations
          [1 ] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
          [2 ] Department of Traditional Chinese Medicine, The Seventh People's Hospital of Hangzhou, Hangzhou, Zhejiang 310003, China.
          [3 ] Department of Psychiatry, The Seventh People's Hospital of Hangzhou, Hangzhou, Zhejiang 310003, China.
          [4 ] Department of Psychiatry, Psychiatric Hospital of Hengshui, Hebei 053000, China.
          [5 ] Department of Infectious Diseases, Huzhou Central Hospital, Huzhou, Zhejiang 313000, China.
          [6 ] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Electronic address: ljli@zju.edu.cn.
          [7 ] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Electronic address: hzruanbing@gmail.com.
          Article
          S0889-1591(15)00110-5
          10.1016/j.bbi.2015.03.016
          25882912
          b3520ade-14a1-49a8-96cf-856962754b5a
          Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Antidepressant,Depression,Gut bacteria,Gut–brain,Inflammation

          Comments

          Comment on this article